Prevalence of obstructive sleep apnea syndrome in hospitalized patients with type 2 diabetes in Beijing, China.
Obstructive sleep apnea
Prevalence
Type 2 diabetes
Journal
Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
revised:
06
06
2022
received:
28
03
2022
accepted:
10
06
2022
pubmed:
3
7
2022
medline:
3
11
2022
entrez:
2
7
2022
Statut:
ppublish
Résumé
To estimate the prevalence, and patient clinical and demographic profile, as well as risk factors associated with obstructive sleep apnea syndrome (OSAS) in hospitalized patients with type 2 diabetes mellitus in Beijing, China. Hospitalized adult patients with type 2 diabetes mellitus were consecutively screened and invited for an overnight polysomnography from four hospitals in Beijing, China, from May 2016 to February 2017. We used the American Academy of Sleep Medicine 2012 polysomnography recording techniques and scoring criteria to identify the type of apnea and the severity of OSAS. The χ A total of 735 patients were found eligible for the study, of whom 309 patients completed the overnight polysomnography. The mean age of the patients was 58.2 ± 10.9 years, and most (67.3%) were men. The prevalence of overall (apnea hypopnea index ≥5/h), moderate-to-severe (apnea hypopnea index ≥15/h) and severe (apnea hypopnea index ≥30/h) OSAS was 66.3% (95% confidence interval 60.8-71.6%), 35.6% (95% confidence interval 30.3-41.2%) and 16.5% (95% confidence interval 12.5-21.1%), respectively. Central and mixed apnea contributed 12% to all sleep-disordered breathing. With the aggravation of OSAS, the combined prevalence for central, mixed and obstructive apnea increased from 57% to 70%. We found OSAS to be associated with older age, obesity, self-reported snoring and apnea, and diabetes complications. Guidelines on screening and treatment of OSAS among hospitalized patients with diabetes are needed to direct the routine practice for diabetes endocrinologists for optimal clinical care of such patients.
Identifiants
pubmed: 35778970
doi: 10.1111/jdi.13868
pmc: PMC9623507
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1889-1896Subventions
Organisme : Beijing Municipal Science and Technology Commission
ID : D141107005314005
Informations de copyright
© 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Références
Sleep Breath. 2011 Jan;15(1):129-35
pubmed: 20174875
Diabetes Res Clin Pract. 2008 Jul;81(1):2-12
pubmed: 18544448
J Intern Med. 2001 Feb;249(2):153-61
pubmed: 11240844
J Diabetes. 2015 Jan;7(1):16-23
pubmed: 24910109
Am J Epidemiol. 2004 Sep 15;160(6):521-30
pubmed: 15353412
Sleep. 2006 Jun;29(6):777-83
pubmed: 16796216
Endocrine. 2020 Feb;67(2):363-373
pubmed: 31927752
Diabetes Care. 2009 Jun;32(6):1017-9
pubmed: 19279303
Am J Respir Crit Care Med. 2005 Dec 15;172(12):1590-5
pubmed: 16192452
J Clin Sleep Med. 2009 Feb 15;5(1):15-20
pubmed: 19317376
Sleep Breath. 2011 Sep;15(3):295-300
pubmed: 20607426
J Sleep Res. 2016 Feb;25(1):39-46
pubmed: 26268508
Am J Respir Crit Care Med. 2002 Mar 1;165(5):677-82
pubmed: 11874813
Am J Respir Crit Care Med. 2012 Sep 1;186(5):434-41
pubmed: 22723291
J Clin Sleep Med. 2012 Oct 15;8(5):597-619
pubmed: 23066376
J Clin Sleep Med. 2017 Apr 15;13(4):583-589
pubmed: 28162147
Prog Cardiovasc Dis. 2009 Jan-Feb;51(4):285-93
pubmed: 19110130
Respirology. 2016 Jul;21(5):943-50
pubmed: 26929251
BMJ Open. 2018 Oct 15;8(10):e022752
pubmed: 30327404
Am J Respir Crit Care Med. 2002 Mar 1;165(5):670-6
pubmed: 11874812
Chest. 2019 Jun;155(6):1190-1198
pubmed: 30948225
Respir Med. 1998 Jun;92(6):843-8
pubmed: 9850368
Chest. 2010 Nov;138(5):1101-7
pubmed: 20705796
Diabet Med. 2010 Apr;27(4):423-30
pubmed: 20536514